WFM
INSM icon

Wilmington Funds Management’s Insmed INSM Stock Holding History

Wilmington Funds Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-12,025
Closed -$229K – 777
2014
Q1 		$229K Buy
+12,025
New +$229K 0.02% 623

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wilmington Funds Management's INSM Position: Q2 2014 in Review

Wilmington Funds Management sold out of Insmed (INSM) in Q2 2014, closing a stake of 12,025 shares — an estimated $229K sold.

Wilmington Funds Management first reported a position in INSM in Q1 2014 and held it in 1 quarter. The position peaked at $229K in Q1 2014. 103 funds tracked by Wall St. Rank hold INSM as of Q2 2014.

  • Wilmington Funds Management reported no remaining Insmed position as of Q2 2014 after selling out during the quarter.
  • Wilmington Funds Management sold 12,025 Insmed shares in Q2 2014, an estimated $229K.
  • Wilmington Funds Management first reported a position in Insmed in Q1 2014 and held it in 1 quarter.
  • Wilmington Funds Management's Insmed position peaked at $229K in Q1 2014.
  • 103 funds tracked by Wall St. Rank held Insmed as of Q2 2014.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.